MDMA (3,4-methylenedioxymethamphetamine), historically recognized as a synthetic substance associated with recreational use, has transitioned into a subject of significant clinical interest. By 2026, the medical community—supported by evolving regulatory frameworks—is actively researching and, in limited jurisdictions, utilizing pharmaceutical-grade MDMA-assisted therapy to address severe, treatment-resistant mental health conditions. Table of Contents Emerging Medical Indications While MDMA […]